Journal of Current Glaucoma Practice

Register      Login

VOLUME 12 , ISSUE 3 ( September-December, 2018 ) > List of Articles

EDITORIAL

The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End?

Shibal Bhartiya, Tarek Shaarawy

Citation Information : Bhartiya S, Shaarawy T. The Quest for the Holy Grail of Glaucoma Surgery: Does Cypass Herald the End?. J Curr Glaucoma Pract 2018; 12 (3):99-101.

DOI: 10.5005/jp-journals-10078-1231

License: CC BY-NC 4.0

Published Online: 00-12-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017;12: e0183142.
  2. Sharaawy T, Bhartiya S. Surgical management of glaucoma: evolving paradigms. Indian J Ophthalmol. 2011;59 Suppl: S123-30.
  3. Sng CCA, Barton K Minimally invasive glaucoma surgery - coming of age. Br J Ophthalmol. 2018;102:1315-1316.
  4. Janson BJ, Alward WL, Kwon YH, Bettis DI, Fingert JH, Provencher LM, Goins KM, Wagoner MD, Greiner MA. Glaucoma-associated corneal endothelial cell damage: A review. Surv Ophthalmol. 2018;63:500-506.
  5. Lass JH1, Khosrof SA, Laurence JK, Horwitz B, Ghosh K, Adamsons I. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group. Arch Ophthalmol. 1998;116:1003-1010.
  6. Shimazaki J, Amano S, Uno T, et al. Japan Bullous Keratopathy Study Group. National survey on bullous keratopathy in Japan. Cornea 2007;26:274-278.
  7. Wang PX, Koh VT, Loon SC. Laser iridotomy and the corneal endothelium: a systemic review. Acta Ophthalmol 2014;92:604-616. Eye (Lond). 2014;28:47-52.
  8. Ong K, Ong L, Ong LB. Corneal endothelial abnormalities after selective laser trabeculoplasty (SLT). J Glaucoma. 2015;24:286-290.
  9. Arnavielle S, Lafontaine PO, Bidot S, et al. Corneal endothelial cell changes after trabeculectomy and deep sclerectomy. J Glaucoma. 2007;16:324e8.
  10. Shin DB, Lee SB, Kim CS. Effects of viscoelastic material on the corneal endothelial cells in trabeculectomy with adjunctive mitomycin-C. Korean J Ophthalmol. 2003;17:83e90.
  11. Sihota R, Sharma T, Agarwal HC. Intraoperative mitomycin C and the corneal endothelium. Acta Ophthalmol Scand. 1998;76:80e2.
  12. Storr-Paulsen T, Norregaard JC, Ahmed S, Storr-Paulsen A. Corneal endothelial cell loss after mitomycin C-augmented trabeculectomy. J Glaucoma. 2008;17:654e7.
  13. Kim MS, Kim KN, Kim CS. Changes in corneal endothelial cell after Ahmed glaucoma valve implantation and trabeculectomy: 1-year follow-up. Korean J Ophthalmol. 2016;30:416e25.
  14. Lee EK, Yun YJ, Lee JE, et al. Changes in corneal endothelial cells after Ahmed glaucoma valve implantation: 2-year follow-up. Am J Ophthalmol. 2009;148:361e7.
  15. Nassiri N, Nassiri N, Majdi NM, et al. Corneal endothelial cell changes after Ahmed valve and Molteno glaucoma implants. Ophthalmic Surg Lasers Imaging. 2011;42: 394e9.
  16. Mendrinos E, Dosso A, Sommerhalder J, Shaarawy T. Coupling of HRT II and AS-OCT to evaluate corneal endothelial cell loss and in vivo visualization of the Ahmed glaucoma valve implant. Eye (Lond). 2009;23:1836e44.
  17. Tan AN, Webers CA, Berendschot TT, et al. Corneal endothelial cell loss after Baerveldt glaucoma drainage device implantation in the anterior chamber. Acta Ophthalmol. 2017;95:91e6.
  18. Fea AM, Spinetta R, Cannizzo PML, Consolandi G, Lavia C, Aragno V, Germinetti F, Rolle T. Evaluation of Bleb Morphology and Reduction in IOP and Glaucoma Medication following Implantation of a Novel Gel Stent. J Ophthalmol. 2017;2017:9364910.
  19. Fea AM, Consolandi G, Pignata G, Cannizzo PM, Lavia C, Billia F, Rolle T, Grignolo FM. A Comparison of Endothelial Cell Loss in Combined Cataract and MIGS (Hydrus) Procedure to Phacoemulsification Alone: 6-Month Results. J Ophthalmol. 2015;2015:769289.
  20. Personal communication to Hydrus investigators from Brett Trauthen, chief Scientific Officer, Ivantis.
  21. http://ascrs.org/CyPass_Statement. Accessed 29.10.2018
  22. https://www.accessdata.fda.gov/cdrh_docs/pdf15/p150037d. pdf accessed 29.10.2018
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.